Investment analysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research note issued to investors on Sunday. The brokerage set a “sell” rating on the stock.
Ampio Pharmaceuticals Stock Performance
Ampio Pharmaceuticals stock opened at $0.50 on Friday. Ampio Pharmaceuticals has a 1 year low of $0.14 and a 1 year high of $8.30. The firm’s 50 day moving average price is $1.30 and its two-hundred day moving average price is $1.94. The firm has a market cap of $565,519.80, a price-to-earnings ratio of -0.05 and a beta of 1.96.
Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) last released its quarterly earnings results on Wednesday, March 27th. The company reported ($2.48) earnings per share for the quarter.
About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
See Also
- Five stocks we like better than Ampio Pharmaceuticals
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- Consumer Staples Stocks, Explained
- Merger or Not, Albertson’s Companies is a Good Buy
- How Can Investors Benefit From After-Hours Trading
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
